Parkinson's Disease
Conditions
Keywords
Health pathway, patient centered care, communication aid- tool, primary care, secondary care
Brief summary
PARKINSUN is a new communication aid tool, expected to favor global patient centered care for PD patients during consultation with GPs and neurologists. Two groups of patients will be randomized to use or not PARKINSUN when they consult their physicians every 3 months during 7 months.
Interventions
OTHERConsulting with PARKINSUN as communication aid-tool
Participating patients visit their general practitioner or neurologist with PARKINSUN at 1 months, 4 months, 7 months
OTHERConsulting without PARKINSUN as communication aid-tool
Participating patients visit their general practitioner or neurologist without PARKINSUN at 1 months, 4 months, 7 months
Sponsors
Expert center of Parkinson's Disease (CHU Lille)
College of teaching general practitioners (CEMG Lille)
Regional Health Agency (ARS)
UCB Pharma
Orkyn'
University Hospital, Lille
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No
Inclusion criteria
* Adult men and women with all stages of PD * Without severe chronic neurological or mental or psychiatric pathology * Absence of cognitive impairment affecting autonomy (MDS criteria of dementia and MOCA \> 22) * able to come (alone or accompanied) to consultation * Affiliate or beneficiary of a social security scheme * Subject having signed informed consent * Patient willing to comply with all procedures of the study and its duration
Exclusion criteria
* Administrative reasons: impossibility of receiving informed information, inability to participate in the whole study, absence of coverage by the social security system, refusal to sign consent. * Subject under tutelage or curtailer. * Subject not fluent in the French language to understand the instructions necessary to carry out the cognitive tests.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| variation of the delta of G-MISS Questionnaire | at 7 months |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Global score of PARKINSUN | at the end of each consultation ((1 month and 7 months) | — |
| Individuals scores of PARKINSUN | at the end of each consultation ((1 month and 7 months) | — |
| MDS-UPDRS scores | at the end of each consultation ((1 month and 7 months) | — |
| G-MISS-Questionnaire at the end of each consultation (1 month, 4 months and 7 months) | at the end of each consultation (1 month and 7 months) | Patient's satisfaction will be assessed by the G-MISS-Questionnaire. The G-MISS questionnaire is a standardized and validated tool in French. This questionnaire is taken from the American MISS-21 questionnaire, already used in neurologists to measure the satisfaction of patients with PD, after consultation It is easy to use with an average filling time of 6 minutes. |
| Likert Scale | at the end of each consultation (1 month and 7 months) | — |
| Interpersonal Reactivity Index (IRI) | at the end of each consultation (1 month and 7 months) | — |
| PDQ-39 scores 6. Interpersonal Reactivity Index (IRI) | at the end of each consultation ((1 month and 7 months) | — |
Countries
France
Contacts
Primary ContactDavid Devos, MD,PhD
Outcome results
None listed